Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes

Circulation Research

Volumn 90, Issue 10, 2002, Pages 1064-1071

  Pinderski, Laura J ^a   Fischbein, Michael P ^a   Subbanagounder, Ganesamoorthy ^a   Fishbein, Michael C ^a   Kubo, Nobuhiko ^a   Cheroutre, Hilde ^a   Curtiss, Linda K ^a   Berliner, Judith A ^a   Boisvert, William A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Antibodies; Apoptosis; B lymphocytes; Cytokine; LDL receptor

Indexed keywords

CHOLESTEROL; GAMMA INTERFERON; IMMUNOGLOBULIN G1; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOAM CELL; GENE REARRANGEMENT; LIPID OXIDATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; AORTA; ARTERIOSCLEROSIS; BONE MARROW TRANSPLANTATION; FLOW CYTOMETRY; IMMUNOGLOBULINS; INTERLEUKIN-10; LIPIDS; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MONOCYTES; PHENOTYPE; RECEPTORS, LDL; T-LYMPHOCYTES, HELPER-INDUCER; TH2 CELLS;

EID: 0037205317     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000018941.10726.FA     Document Type: Article

References (37)

1. Protective role of interleukin-10 in atherosclerosis
2. Interleukin-10 blocks atherosclerotic events in vitro and in vivo
3. Atherosclerosis, basic mechanisms: Oxidation, inflammation, and genetics
4. Expression of interleukin-10 in advanced human atherosclerotic plaques: Relation to inducible nitric oxide synthase expression and cell death
5. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis
6. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina
7. Altered immune responses in interleukin 10 transgenic mice
8. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice
9. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophagestimulating cytokines
10. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice
11. Role of leukocyte-specific LDL receptors on plasma lipoprotein cholesterol and atherosclerosis in mice
12. Interferon-γ-secreting T-cell populations in rejecting murine cardiac allografts: Assessment by flow cytometry
13. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
14. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
15. The role of oxidized LDL in atherogenesis: Immunological response and anti-phospholipid antibodies
16. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice: Decreasing density with disease progression
17. Murine macrophages secrete interferon-γ upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation
18. Macrophages are a significant source of type 1 cytokines during mycobacterial infection
19. Effect of γ-irradiation and bone marrow transplantation on atherosclerosis in LDL receptordeficient mice
20. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells
21. Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10
22. Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10
23. Molecular determinants of atherosclerotic plaque vulnerability
24. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice
25. IFN-γ potentiates atherosclerosis in ApoE knock-out mice
26. Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice
27. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice
28. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis
29. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice
30. Atherosclerosis: An inflammatory disease
31. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes: A regulatory role for plasma LDL
32. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor
33. Role of macrophage colony-stimulating factor in atherosclerosis: Studies of osteopetrotic mice
34. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collageninduced arthritis in both injected and uninjected paws
35. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
36. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
37. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway: A target of interleukin (IL)-4 and IL-10 anti-inflammatory action